非心房颤动患者心房18F-氟脱氧葡萄糖摄取与既往缺血性卒中的关联
研究纳入1444例非心房颤动住院患者,其中196例心房FDG摄取增强,392例无心房活性者作为对照。心房活性增强者既往缺血性卒中患病率更高(12.2% vs 3.3%,P < .001),多因素回归显示心房活性与缺血性卒中独立相关(OR 4.02,95% CI 1.97-8.19,P < .001)。
要点
- 非心房颤动患者中心房FDG摄取增强与既往缺血性卒中史相关(12.2% vs 3.3%,P < .001)。
- 心房活性是缺血性卒中的独立相关因素(OR 4.02,95% CI 1.97-8.19,P < .001)。
- 校正心房心肌病后心房活性仍与卒中相关(OR 3.63,95% CI 1.51-8.74,P = .004)。
核心结论
- 在非心房颤动个体中,心房FDG活性与缺血性卒中史及心房心肌病存在关联,需进一步纵向研究论证其因果关系。
研究设计与样本
- 研究初始识别1444例非心房颤动住院患者,其中心房FDG摄取增强者196例,另选无心房活性者392例作为对照,分析心房活性、缺血性卒中史与心房心肌病。
主要发现
- 心房心肌病患者心房活性增强的患病率高于无心房心肌病患者(47.1% vs 26.0%,P < .001)。
- 心房活性增强患者既往缺血性卒中史患病率高于无心房活性患者(12.2% vs 3.3%,P < .001)。
- 多因素回归分析显示,校正危险因素后心房活性与缺血性卒中独立相关(OR 4.02,95% CI 1.97-8.19,P < .001)。
- 校正心房心肌病后心房活性仍与缺血性卒中独立相关(OR 3.63,95% CI 1.51-8.74,P = .004)。
关键数值与推荐
- 心房心肌病患者心房活性增强患病率为47.1%,无心房心肌病患者为26.0%(P < .001)。
- 心房活性增强患者既往缺血性卒中史患病率为12.2%,无心房活性患者为3.3%(P < .001)。
- 校正危险因素后心房活性与缺血性卒中的OR为4.02(95% CI 1.97-8.19,P < .001)。
- 校正心房心肌病后心房活性与缺血性卒中的OR为3.63(95% CI 1.51-8.74,P = .004)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文结论指出需进一步纵向研究以论证心房FDG活性与缺血性卒中及心房心肌病的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atrial cardiomyopathy has gained increasing attention in the field of ischemic stroke due to its prothrombotic substrate. Timely identification of high-risk individuals without atrial fibrillation (AF) is essential in secondary prevention. We sought to explore the feasibility of atrial 18F-fluorodeoxyglucose (FDG) imaging in detecting diseased atrial substrate and in identifying ischemic stroke in a non-AF population. METHODS: 1444 non-AF inpatients were initially identified. Among them, 196 patients had enhanced atrial FDG uptake, while 392 patients without atrial activity were selected as controls. Atrial activity, the history of ischemic stroke, and atrial cardiomyopathy were analyzed. RESULTS: Patients with atrial cardiomyopathy had a higher prevalence of enhanced atrial activity (47.1% vs 26.0%, P < .001), and patients with increased atrial activity had a higher prevalence of a prior history of ischemic stroke (12.2% vs 3.3%, P < .001). Multivariate regression analysis demonstrated that atrial activity was independently related to ischemic stroke after adjustment for risk factors (OR 4.02, 95% CI 1.97-8.19, P < .001) and atrial cardiomyopathy (OR 3.63, 95% CI 1.51-8.74, P = .004). CONCLUSIONS: This study identified an association between atrial FDG activity and a history of ischemic stroke and atrial cardiomyopathy in non-AF individuals. Further longitudinal study is warranted to demonstrate their causal relationship.
引用
- Su Y, Chen BX, Wang Y, et al. Association of atrial 18F-fluorodeoxyglucose uptake and prior ischemic stroke in non-atrial fibrillation patients. J Nucl Cardiol. 2022. PMID: 35083714. doi:10.1007/s12350-022-02903-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。